Green Cross Valuation
| 144510 Stock | KRW 23,500 750.00 3.09% |
At this time, the firm appears to be overvalued. Green Cross Lab retains a regular Real Value of W22165.5 per share. The prevalent price of the firm is W23500.0. Our model calculates the value of Green Cross Lab from evaluating the firm fundamentals such as Return On Asset of 0.0765, current valuation of 1.06 T, and Return On Equity of 16.95 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Green Cross' price fluctuation is very steady at this time. Calculation of the real value of Green Cross Lab is based on 3 months time horizon. Increasing Green Cross' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Green Cross is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Green Stock. However, Green Cross' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 23500.0 | Real 22165.5 | Hype 23500.0 | Naive 23231.14 |
The real value of Green Stock, also known as its intrinsic value, is the underlying worth of Green Cross Lab Company, which is reflected in its stock price. It is based on Green Cross' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Green Cross' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Green Cross Lab helps investors to forecast how Green stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Green Cross more accurately as focusing exclusively on Green Cross' fundamentals will not take into account other important factors: Green Cross Total Value Analysis
Green Cross Lab is presently forecasted to have takeover price of 1.06 T with market capitalization of 493.93 B, debt of 31.99 B, and cash on hands of 18 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Green Cross fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.06 T | 493.93 B | 31.99 B | 18 B |
Green Cross Investor Information
About 50.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Based on the key indicators related to Green Cross' liquidity, profitability, solvency, and operating efficiency, Green Cross Lab is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Green Cross Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Green Cross has an asset utilization ratio of 26.07 percent. This suggests that the Company is making W0.26 for each dollar of assets. An increasing asset utilization means that Green Cross Lab is more efficient with each dollar of assets it utilizes for everyday operations.Green Cross Ownership Allocation
The market capitalization of Green Cross is W493.93 Billion. Green Cross secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.Green Cross Profitability Analysis
The company reported the revenue of 168.31 B. Net Income was 30.06 B with profit before overhead, payroll, taxes, and interest of 23.28 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Green Cross' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Green Cross and how it compares across the competition.
About Green Cross Valuation
The stock valuation mechanism determines Green Cross' current worth on a weekly basis. Our valuation model uses a comparative analysis of Green Cross. We calculate exposure to Green Cross's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Green Cross's related companies.Green Cross Lab Cell Corporation develops cell therapy products. The company was founded in 2011 and is based in Yongin, South Korea. Green Cross is traded on Korean Securities Dealers Automated Quotations in South Korea.
8 Steps to conduct Green Cross' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Green Cross' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Green Cross' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Green Cross' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Green Cross' revenue streams: Identify Green Cross' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Green Cross' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Green Cross' growth potential: Evaluate Green Cross' management, business model, and growth potential.
- Determine Green Cross' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Green Cross' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Green Stock analysis
When running Green Cross' price analysis, check to measure Green Cross' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Green Cross is operating at the current time. Most of Green Cross' value examination focuses on studying past and present price action to predict the probability of Green Cross' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Green Cross' price. Additionally, you may evaluate how the addition of Green Cross to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |